Annual D&A
$71.55 M
+$27.13 M+61.07%
December 31, 2023
Summary
- As of February 8, 2025, DNA annual depreciation & amortization is $71.55 million, with the most recent change of +$27.13 million (+61.07%) on December 31, 2023.
- During the last 3 years, DNA annual D&A has risen by +$57.69 million (+416.11%).
- DNA annual D&A is now at all-time high.
Performance
DNA Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$17.17 M
-$161.00 K-0.93%
September 30, 2024
Summary
- As of February 8, 2025, DNA quarterly depreciation & amortization is $17.17 million, with the most recent change of -$161.00 thousand (-0.93%) on September 30, 2024.
- Over the past year, DNA quarterly D&A has increased by +$3.29 million (+23.66%).
- DNA quarterly D&A is now -18.48% below its all-time high of $21.06 million, reached on September 30, 2023.
Performance
DNA Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$61.25 M
-$3.89 M-5.97%
September 30, 2024
Summary
- As of February 8, 2025, DNA TTM depreciation & amortization is $61.25 million, with the most recent change of -$3.89 million (-5.97%) on September 30, 2024.
- Over the past year, DNA TTM D&A has dropped by -$10.30 million (-14.40%).
- DNA TTM D&A is now -18.56% below its all-time high of $75.21 million, reached on September 30, 2023.
Performance
DNA TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
DNA Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +61.1% | +23.7% | -14.4% |
| 3 y3 years | +416.1% | +23.7% | -14.4% |
| 5 y5 years | +565.3% | - | - |
DNA Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +146.1% | -18.5% | +117.0% | -18.6% | +110.7% |
| 5 y | 5-year | at high | +565.3% | -18.5% | +205.0% | -18.6% | +988.1% |
| alltime | all time | at high | +565.3% | -18.5% | +205.0% | -18.6% | +988.1% |
Ginkgo Bioworks Holdings Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $17.17 M(-0.9%) | $61.25 M(-6.0%) |
| Jun 2024 | - | $17.33 M(+34.7%) | $65.14 M(-0.5%) |
| Mar 2024 | - | $12.87 M(-7.3%) | $65.47 M(-8.5%) |
| Dec 2023 | $71.55 M(+61.1%) | $13.88 M(-34.1%) | $71.55 M(-4.9%) |
| Sep 2023 | - | $21.06 M(+19.3%) | $75.21 M(+21.2%) |
| Jun 2023 | - | $17.65 M(-6.9%) | $62.06 M(+14.0%) |
| Mar 2023 | - | $18.96 M(+8.1%) | $54.44 M(+22.6%) |
| Dec 2022 | $44.42 M | $17.54 M(+121.6%) | $44.42 M(+27.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | $7.91 M(-21.1%) | $34.89 M(-1.0%) |
| Jun 2022 | - | $10.03 M(+12.2%) | $35.25 M(+8.9%) |
| Mar 2022 | - | $8.94 M(+11.7%) | $32.39 M(+11.4%) |
| Dec 2021 | $29.08 M(+109.7%) | $8.00 M(-3.3%) | $29.08 M(+38.0%) |
| Sep 2021 | - | $8.28 M(+15.5%) | $21.07 M(+64.7%) |
| Jun 2021 | - | $7.17 M(+27.3%) | $12.79 M(+127.3%) |
| Mar 2021 | - | $5.63 M | $5.63 M |
| Dec 2020 | $13.86 M(+28.9%) | - | - |
| Dec 2019 | $10.76 M | - | - |
FAQ
- What is Ginkgo Bioworks Holdings annual depreciation & amortization?
- What is the all time high annual D&A for Ginkgo Bioworks Holdings?
- What is Ginkgo Bioworks Holdings annual D&A year-on-year change?
- What is Ginkgo Bioworks Holdings quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Ginkgo Bioworks Holdings?
- What is Ginkgo Bioworks Holdings quarterly D&A year-on-year change?
- What is Ginkgo Bioworks Holdings TTM depreciation & amortization?
- What is the all time high TTM D&A for Ginkgo Bioworks Holdings?
- What is Ginkgo Bioworks Holdings TTM D&A year-on-year change?
What is Ginkgo Bioworks Holdings annual depreciation & amortization?
The current annual D&A of DNA is $71.55 M
What is the all time high annual D&A for Ginkgo Bioworks Holdings?
Ginkgo Bioworks Holdings all-time high annual depreciation & amortization is $71.55 M
What is Ginkgo Bioworks Holdings annual D&A year-on-year change?
Over the past year, DNA annual depreciation & amortization has changed by +$27.13 M (+61.07%)
What is Ginkgo Bioworks Holdings quarterly depreciation & amortization?
The current quarterly D&A of DNA is $17.17 M
What is the all time high quarterly D&A for Ginkgo Bioworks Holdings?
Ginkgo Bioworks Holdings all-time high quarterly depreciation & amortization is $21.06 M
What is Ginkgo Bioworks Holdings quarterly D&A year-on-year change?
Over the past year, DNA quarterly depreciation & amortization has changed by +$3.29 M (+23.66%)
What is Ginkgo Bioworks Holdings TTM depreciation & amortization?
The current TTM D&A of DNA is $61.25 M
What is the all time high TTM D&A for Ginkgo Bioworks Holdings?
Ginkgo Bioworks Holdings all-time high TTM depreciation & amortization is $75.21 M
What is Ginkgo Bioworks Holdings TTM D&A year-on-year change?
Over the past year, DNA TTM depreciation & amortization has changed by -$10.30 M (-14.40%)